Which of the following is the purpose of postmarketing monitoring of new drugs?
Testing for purity and effectiveness of new drugs
Monitoring the quality of new drugs
Ensuring GMP
Removal of unsafe drugs
Removal of unsafe drugs
Rationale: Removal of unsafe drugs is the purpose of postmarketing monitoring of new drugs. It is a tool for quality assurance, ensuring that medications are pure, safe, and effective. Adverse effects are monitored, and any potential for harm is noted. If the medication may be detrimental to individuals, it may be pulled from the market by the manufacturer or the FDA.
You might also like to view...
Career firefighters banded together to form a(n) ____, the International Association of Fire Fighters (IAFF).
A. social club B. research and development team C. labor union D. engineering firm
Homocystinuria results from autosomal defects in:
A) the gene for 6-pyruvoyltertrahydropterin synthase mutations on chromosome 11q22-23.3. B) the E3 gene located on chromosome 7q31-32. C) biosynthesis of biopterin cofactor. D) the cystathionine ?-synthase (CBS) gene on chromosome 21q22.3, which encodes for CBS.
________ tests are the least complex and will have the least risk if they are performed incorrectly.
A. Level II B. Level I C. Certificate of Waiver D. Level III
For an AP axial clavicle projection,
1. the patient's shoulders are positioned at equal distances from the IR. 2. the central ray is angled 15 to 30 degrees cephalad. 3. a compensating filter is positioned over or under the lateral clavicle. 4. the central ray is centered halfway between the medial and lateral clavicular ends. a. 2 and 4 only b. 1 and 3 only c. 1, 3, and 4 only d. 1, 2, 3, and 4